Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | EVP, General Counsel | May 15, 2023 | May 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 15, 2023 · Filed May 17, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 267,095 |
Reported balance
After 2023-05-15 transaction · row 1
1 source rowRow 1 · 2023-05-15 · Tax withholding · Disposed 4,947 · Balance 267,095 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed May 17, 2023 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,947 | $18.73 | $92,657.31 |
DisclosureSEC source: 0001062993-23-011358 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,095 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2023 Filed May 12, 2023 13:02 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,186 | $18.39 | $132,150.54 |
DisclosureSEC source: 0001062993-23-010873 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,042 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 21:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 32,878 | $13.06 | $429,386.68 |
DisclosureSEC source: 0001062993-23-007083 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,228 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 35,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005700 · form4.xml · nonDerivative · entry 2 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,106 F2 · security: Restricted stock which vests on March 15, 2024. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 13:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 42,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005700 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,956 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:33 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 32 | $16.52 | $528.77 |
DisclosureSEC source: 0001062993-23-000311 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,857 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:55 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 551 | $27.18 | $14,973.43 |
DisclosureSEC source: 0001062993-22-015960 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,825 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2022 Filed May 17, 2022 20:05 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,695 | $36.05 | $97,154.75 |
DisclosureSEC source: 0001062993-22-012722 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,274 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 11, 2022 Filed May 12, 2022 21:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,185 | $37.62 | $270,299.70 |
DisclosureSEC source: 0001062993-22-012287 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,969 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:56 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 61,184 | $42.77 | $2,616,839.68 |
DisclosureSEC source: 0001062993-22-007022 · form4.xml · nonDerivative · entry 2 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,154 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 23:56 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 15,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-007022 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,338 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:43 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 96,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003844 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,140 F1 · security: Restricted stock which vests on March 15, 2023. F2 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 100 | $45.50 | $4,550.00 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 11 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,415 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 643 | $45.16 | $29,035.31 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 10 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,515 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F12 · price: Weighted average of the sale price range of $44.50 through $45.43 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 600 | $43.85 | $26,312.40 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 9 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,158 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F11 · price: Weighted average of the sale price range of $43.43 through $44.16 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,400 | $42.59 | $102,225.60 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 8 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,758 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F10 · price: Weighted average of the sale price range of $42.20 through $42.98 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,267 | $41.42 | $218,164.41 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 7 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,158 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F9 · price: Weighted average of the sale price range of $41.12 through $42.10 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,900 | $45.41 | $86,284.70 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 6 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,425 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F8 · price: Weighted average of the sale price range of $45.31 through $45.62 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,394 | $44.94 | $107,591.15 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 5 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,325 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F7 · price: Weighted average of the sale price range of $44.30 through $45.30 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 3,318 | $43.83 | $145,427.94 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 4 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,719 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F6 · price: Weighted average of the sale price range of $43.23 through $44.18 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 13,639 | $42.61 | $581,130.51 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 3 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,037 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F5 · price: Weighted average of the sale price range of $42.15 through $43.08 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 17,956 | $41.51 | $745,281.74 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 2 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,676 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F4 · price: Weighted average of the sale price range of $41.15 through $42.10 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 23:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 1,153 | $40.75 | $46,983.60 |
DisclosureSEC source: 0001062993-21-010282 · form4.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP General Counsel & CorpSec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,632 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. F2 · price: Weighted average of the sale price range of $40.15 through $41.12 F3 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| May 11, 2021 Filed May 13, 2021 13:00 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 7,403 | $33.41 | $247,334.23 |
DisclosureSEC source: 0000075252-21-000103 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,133 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 14:14 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 9,155 | $31.89 | $291,952.95 |
DisclosureSEC source: 0000075252-21-000057 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,536 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 37,214 | $34.12 | $1,269,741.68 |
DisclosureSEC source: 0000075252-21-000047 · edgar.xml · nonDerivative · entry 2 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,691 F2 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective November 24, 2020. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:38 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 17,575 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000047 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,905 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:14 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 123,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000022 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,330 F1 · security: Restricted stock which vests on March 4, 2022. Read SEC document |
| February 08, 2021 Filed Feb 9, 2021 21:23 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 14,870 | $29.29 | $435,542.30 |
DisclosureSEC source: 0000075252-21-000016 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,306 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. F2 · balance_after: Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:09 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 48,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000068 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,741 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 22:16 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,279 | $6.74 | $42,320.46 |
DisclosureSEC source: 0000075252-20-000029 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,465 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:44 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,972 | $6.24 | $12,305.28 |
DisclosureSEC source: 0000075252-20-000012 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,744 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. F2 · balance_after: Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:34 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 61,512 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000041 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,768 F1 · security: Restricted stock grant which vests one-third per year over three years. F2 · balance_after: Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 20:53 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,066 | $7.52 | $15,536.32 |
DisclosureSEC source: 0000075252-19-000015 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,259 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| February 08, 2018 Filed Feb 12, 2018 21:29 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 44,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-18-000035 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,325 F1 · security: Restricted stock with three year vesting date. F2 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 23:21 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,204 | $21.06 | $88,536.24 |
DisclosureSEC source: 0000075252-18-000017 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,838 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:04 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 5,569 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000027 · edgar.xml · nonDerivative · entry 1 Pace Nicholas J · CIK 0001497051 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,042 F1 · security: Restricted stock with three year vesting date. F2 · balance_after: Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.